Swedish hockey team jumps the queue, gets swine flu vaccine early!!!
Tommy Grand
Get your shot today before someone takes it from you!!
Tashi
> http://www.thelocal.se/22956/20091029/
>
> Get your shot today before someone takes it from you!!
I like the comments.......
I guess this is positive news for everybody who is
antiswinefluvaccine.
Being that the Team is in the public eye, if they start dropping off
like flies, or suffering from some weird side effects, it will be very
difficult to hide so just find out which team it is and keep an eye on
them.
i suppose if they lose the next few matches they can blame the
vaccine. it is a good scapegoat to otherwise admitting that their
playing is rubbish...
Andrew Schulman
> http://www.thelocal.se/22956/20091029/
>
> Get your shot today before someone takes it from you!!
>
>
got the H1N1 vaccine there 2 weeks ago.
I asked one of the doctors about clinical trials and she gave me the
article published on October 21 by The New England Journal Of
Medicine. Title of the article is "A Novel Influenza A (H1N1) Vaccine
in Various Age Groups". 2200 subjects, "No severe adverse side
effects associated with the vaccine were noted".
You can read the article here:
http://content.nejm.org/cgi/content/full/NEJMoa0908535?resourcetype=HWCIT
Andrew
Tommy Grand
wrote:
>
> Andrew
Andrew it's better to paste the article because people don't click
links. but this one might interest you:
Scientists, who work for WHO influenza laboratory, hold patent for
bioengineered swine flu virus
Scientists, who work for WHO influenza laboratory, hold patent for
bioengineered swine flu virus
Andrew Schulman
> Andrew it's better to paste the article because people don't click
>
>
Huh?
>
>
> ..but this one might interest you:
>
> Scientists, who work for WHO influenza laboratory, hold patent for
> bioengineered swine flu virus
>
> Scientists, who work for WHO influenza laboratory, hold patent for
> bioengineered swine flu virus
>
>
It doesn't interest me.
Andrew
Tommy Grand
wrote:
>
> - Show quoted text -
Oops
Two of the scientists who filed for a patent for a genetically
engineered, artificial swine flu virus, work for WHO and St Jude's
Children Research Hospital.
New Zealanders Robert Webster and Richard Webby are listed as patent
holders for the US Patent Application 20090010962 - Genetically
Engineered Swine Influenza Virus and Uses Thereof
http://www.patentstorm.us/applications/20090010962/claims.html
Robert Webster holds the Rose Marie Thomas Chair in Virology at St.
Jude Children's Research Hospital. He is also director of the World
Health Organization Collaborating Center on the Ecology of Influenza
Viruses in Lower Animals and Birds, the world's only laboratory
designed to study influenza at the animal-human interface, according
to Wikipedia.
Richard Webby is an Associate Member, St. Jude Faculty and a Director,
World Health Organization Collaborating Center for Studies on the
Ecology of Influenza in Animals and Birds, according to an entry on St
Jude's website.
The claims of the US Patent Application 20090010962 - Genetically
Engineered Swine Influenza Virus and Uses Thereof
are
1. An attenuated swine influenza virus
comprising a mutation in a swine influenza NS1 gene that diminishes
the ability of the NS1 gene product to antagonize the cellular
interferon response, and permits the attenuated virus, at a
multiplicity of infection of 0.001, to grow to titers between
approximately 3 fold to approximately 7 fold lower than wild-type
swine influenza in pig cells, as determined approximately 5 days post-
infection when propagated under the same conditions.
2. The attenuated swine influenza virus of claim 1, wherein the
attenuated virus is genetically engineered.
3. The attenuated swine influenza virus of claim 1, wherein the
attenuated virus is a mutagenized virus or reassortant.
4. The attenuated swine influenza virus of claim 2, wherein the
attenuated virus is a chimeric virus that expresses a heterologous
sequence.
5. The attenuated swine influenza virus of claim 2, wherein the
attenuated virus is a chimeric virus that expresses a tumor antigen.
6. The attenuated swine influenza virus of claim 2, wherein the
attenuated virus is a chimeric virus that expresses an epitope of a
foreign pathogen.
7. The attenuated swine influenza virus of claim 1, wherein pig cells
are PK(D1) cells, PK(15) cells, PK13 cells, NSK cells, LLC-PK1 cells,
LLC-PK1A cells, ESK-4 cells, ST cells, PT-K75 cells, PK-2a/CL 13 cells
or SJPL cells.
8. (canceled)
9. The attenuated swine influenza virus of claim 2, wherein the
mutation is a deletion at the carboxy terminus of the NS1 gene.
10. (canceled)
11. An attenuated swine influenza virus comprising a modified NS1
gene, wherein the attenuated swine influenza virus is TX/98/del 126,
TX/98/del 99 or TX/98/del 73.
12. An attenuated swine influenza virus having an altered interferon
antagonist phenotype, wherein said virus comprises a mutation in the
NS1 gene resulting in a deletion of between the 105 carboxy terminal
amino acid residues and the 160 carboxy terminal amino acid residues
of NS1.
13. The attenuated swine influenza virus of claim 12, wherein the
virus is attenuated by a mutation in the NS1 gene resulting in a
deletion of all of the amino acid residues of NS1 except amino acid
residues 1-95, amino acid residues 1-90, amino acid residues 1-85,
amino acid residues 1-80, amino acid residues 1-75, amino acid
residues 1-73, amino acid residues 1-70, amino acid residues 1-65, or
amino acid residues 1-60, and wherein the amino terminal amino acid is
number 1 and the mutation in the NS1 gene confers an altered
interferon antagonist phenotype.
14. (canceled)
15. A immunogenic formulation comprising the attenuated swine
influenza virus of claim 1, and a physiologically acceptable
excipient.
16. A immunogenic formulation comprising the attenuated swine
influenza virus of claim 11 or 12, and a physiologically acceptable
excipient.
17. A pharmaceutical formulation comprising the attenuated swine
influenza virus of claim 1, and a physiologically acceptable
excipient.
18. A pharmaceutical formulation comprising the attenuated swine
influenza virus of claim 11 or 12, and a physiologically acceptable
excipient.
19-20. (canceled)
21. The immunogenic formulation of claim 15, wherein the attenuated
swine influenza virus is genetically engineered.
22. The immunogenic formulation of claim 21, wherein the attenuated
swine influenza virus is a chimeric virus that expresses a
heterologous sequence.
23-26. (canceled)
27. The pharmaceutical formulation of claim 17, wherein the attenuated
swine influenza virus is genetically engineered.
28-29. (canceled)
30. The pharmaceutical formulation of claim 27, wherein the attenuated
swine influenza virus is a chimeric virus that expresses a tumor
antigen.
31. A method for immunizing or inducing an immune response in a pig,
comprising administering to said pig an effective amount of the
immunogenic formulation of claim 21.
32. A method for immunizing or inducing an immune response a pig,
comprising administering to said pig an effective amount of the
immunogenic formulation of claim 16.
33. A method of treating a swine influenza virus infection in a pig,
comprising administering to said pig an effective amount of the
pharmaceutical formulation of claim 27.
34. A method of treating a swine influenza virus infection in a pig,
comprising administering to said pig an effective amount of the
pharmaceutical formulation of claim 18.
35. A method of treating cancer in a pig, comprising administering to
said pig an effective amount of the pharmaceutical formulation of
claim 30.
36-40. (canceled)
41. A method for production of an immunogenic formulation comprising:
(a) propagating in a substrate the attenuated swine influenza virus of
claim 1; and(b) collecting progeny virus,wherein the substrate is a
cell, cell line or embryonated egg.
42. A method for production of an immunogenic formulation comprising:
(a) propagating in a substrate the attenuated swine influenza virus of
claim 11 or 12;(b) collecting progeny virus;wherein the substrate is a
cell, cell line or embryonated egg.
43-56. (canceled)
57. A cell containing the attenuated swine influenza virus of claim 1.
58. (canceled)
59. A cell containing the swine influenza virus of claim 11 or 12.
60-69. (canceled)
70. An embryonated egg containing the attenuated swine influenza virus
of claim 1.
71-77. (canceled)
More info under:
Andrew Schulman
> Two of the scientists who filed for a patent for a genetically
> engineered, artificial swine flu virus, work for WHO and St Jude's
> Children Research Hospital.
>
> New Zealanders Robert Webster and Richard Webby are listed as patent
> holders for the US Patent Application 20090010962 - Genetically
> Engineered Swine Influenza Virus and Uses Thereof
>
> http://www.patentstorm.us/applications/20090010962/claims.html
>
>
What I'm interested in is what my doctors tell me, and I'm fortunate
to have excellent doctors, and reports like the New England journal.
Thanks for the info though.
Andrew
Tommy Grand
wrote:
> On Nov 11, 1:13 pm, Tommy Grand <howardj...@yahoo.com> wrote:> Two of the scientists who filed for a patent for a genetically
> > engineered, artificial swine flu virus, work for WHO and St Jude's
> > Children Research Hospital.
>
> > New Zealanders Robert Webster and Richard Webby are listed as patent
> > holders for the US Patent Application 20090010962 - Genetically
> > Engineered Swine Influenza Virus and Uses Thereof
>
> >http://www.patentstorm.us/applications/20090010962/claims.html
>
> And your point is?
That I believe the swine flu stuff is a bunch of marketing hokum.
They make you think you need a vaccine just like they make you think
you need a Wii or an IPod! Unlike Billy Meier, they get rich
Andrew Schulman
> That I believe the swine flu stuff is a bunch of marketing hokum.
> They make you think you need a vaccine just like they make you think
> you need a Wii or an IPod! Unlike Billy Meier, they get rich
>
>
Andrew
Tommy Grand
wrote:
Yes! Probably we'll both live to be old men.
dsi1
Gratuitous post padding! Oh... wait a minute, so is this. Rats!
Andrew Schulman
Andrew
Andrew Schulman
> Gratuitous post padding! Oh... wait a minute, so is this. Rats!
>
>
Andrew